First Trust Advisors LP trimmed its position in Centene Corporation (NYSE:CNC) by 4.3% during the fourth quarter, HoldingsChannel reports. The firm owned 409,298 shares of the company’s stock after selling 18,296 shares during the period. First Trust Advisors LP’s holdings in Centene were worth $41,290,000 at the end of the most recent quarter.
A number of other large investors have also recently added to or reduced their stakes in CNC. Harel Insurance Investments & Financial Services Ltd. acquired a new position in shares of Centene during the 4th quarter valued at about $131,000. SeaCrest Wealth Management LLC acquired a new position in shares of Centene during the 4th quarter valued at about $188,000. Baldwin Brothers Inc. MA acquired a new position in shares of Centene during the 3rd quarter valued at about $185,000. Calamos Advisors LLC acquired a new position in shares of Centene during the 3rd quarter valued at about $207,000. Finally, Commerzbank Aktiengesellschaft FI acquired a new position in shares of Centene during the 3rd quarter valued at about $207,000. Institutional investors own 93.03% of the company’s stock.
Shares of Centene Corporation (CNC) opened at $100.22 on Monday. The company has a debt-to-equity ratio of 0.68, a current ratio of 0.93 and a quick ratio of 0.99. Centene Corporation has a 1 year low of $65.03 and a 1 year high of $112.42. The stock has a market cap of $17,381.86, a P/E ratio of 19.92, a price-to-earnings-growth ratio of 0.96 and a beta of 0.71.
In other Centene news, EVP Keith H. Williamson sold 5,000 shares of the stock in a transaction that occurred on Tuesday, January 2nd. The shares were sold at an average price of $100.11, for a total value of $500,550.00. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, EVP Jesse N. Hunter sold 10,000 shares of the stock in a transaction that occurred on Tuesday, December 19th. The shares were sold at an average price of $98.73, for a total transaction of $987,300.00. The disclosure for this sale can be found here. Insiders sold 32,500 shares of company stock valued at $3,311,613 in the last ninety days. 3.00% of the stock is owned by corporate insiders.
A number of research analysts have recently commented on the stock. ValuEngine raised shares of Centene from a “hold” rating to a “buy” rating in a research note on Friday, February 2nd. Morgan Stanley upped their price objective on shares of Centene from $118.00 to $126.00 and gave the company an “overweight” rating in a research note on Wednesday, February 7th. Credit Suisse Group upped their price objective on shares of Centene from $110.00 to $112.00 and gave the company a “neutral” rating in a research note on Wednesday, February 7th. Cantor Fitzgerald increased their target price on shares of Centene from $115.00 to $125.00 and gave the stock an “overweight” rating in a research report on Wednesday, February 7th. Finally, Citigroup reissued an “outperform” rating and set a $130.00 target price (up previously from $122.00) on shares of Centene in a research report on Wednesday, February 7th. Three equities research analysts have rated the stock with a hold rating, seventeen have given a buy rating and one has given a strong buy rating to the company’s stock. The company has a consensus rating of “Buy” and a consensus target price of $110.28.
Centene Corporation is a healthcare company. The Company provides a portfolio of services to government sponsored healthcare programs, focusing on under-insured and uninsured individuals. The Company operates through two segments: Managed Care and Specialty Services. The Company’s Managed Care segment provides health plan coverage to individuals, through government subsidized programs, including Medicaid, the State Children’s Health Insurance Program (CHIP), Long Term Care, Foster Care, dual-eligible individuals (Duals) and the Supplemental Security Income Program, also known as the Aged, Blind or Disabled Program (ABD), Medicare, and Health Insurance Marketplace.
Want to see what other hedge funds are holding CNC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Centene Corporation (NYSE:CNC).
Receive News & Ratings for Centene Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Centene and related companies with MarketBeat.com's FREE daily email newsletter.